CollPlant Biotechnologies Ltd Proceeds from Issuance or Sale of Equity
CollPlant Biotechnologies Ltd (CLGN) reported Proceeds from Issuance or Sale of Equity of $4.40 million for the 6-month period ending 2020-06-30, per its 6-K filed 2020-08-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2020-08-28
- 2020-06-30: Proceeds from Issuance or Sale of Equity 6 month $4.40M.
| Period end | Proceeds from Issuance or Sale of Equity 6 month |
|---|---|
| 2020-06-30 | $4.40M 6-K · filed 2020-08-28 |